TG Therapeutics, Inc. (TGTX)

NASDAQ: TGTX · Real-Time Price · USD

29.41

-0.49 (-1.64%)

At close: Jan 6, 2026, 4:00 PM EST

29.20

-0.21 (-0.71%)

After-hours: Jan 6, 2026, 7:57 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Novel Treatments for B-cell Diseases	329.00M	Log In	Log In	Log In	Log In	Upgrade
Novel Treatments for B-cell Diseases Growth	40.80%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	329.00M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	40.80%	Log In	Log In	Log In	Log In	Upgrade